<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg Ova with CFA at day 28 after priming immunization (arrows). (A) Ova-specific IgG1 and (B) IgG2c antibody titers are expressed as log<sub>10</sub> titer values, with the titer being the highest dilution that yielded an OD<sub>405</sub> absorbance value two times that of the negative control. Values represent the mean ± SD of samples collected from 14 mice per group (3 separate experiments). Group means were separated using Student's t-test and declared significantly different at a P<0.05. Asterisks indicate significant differences between treatment means.</p
<p>AFCo2 or PLc (100 µg) was admixed with 20 µg of OVA and administered by i.n route to BALB/c mice....
<p>Immunization by intra-rectal route with ovalbumin as antigen (OVA), with cholera toxin (CT) (n = ...
<p>(A) OMV-specific IgGs in BALF were detected in mice that were passively immunized with antiserum;...
<p>(A) IgG1 antibody titers in vaginal washings. Antibody titers are expressed as log<sub>10</sub> t...
<p>Fecal pellets were collected each week from individual mice and fecal extracts were assayed by EL...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
<p>C3H/HeN and C3H/Hen mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekl...
<p>Mice were intranasally immunized with ovalbumin (OVA) plus 0, 2.5, 5, 10, 25, 50, 100, 250, or 50...
Mice were immunized with OVA-PLGA 50:50 core-shell implant (A), with OVA-PLGA 100:0 core-shell impla...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p>Mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekly intervals. One gro...
<p>(A-D and F-H) <i>Cd155<sup>−/−</sup></i> mice (n = 12) and WT littermate (n = 12) were immunize...
The levels of OVA-specific (A) IgE, (B) IgG1 and (C) IgG2a in BALF were detected in mice from PBS, O...
<p>BALB/c female mice were immunized intranasally with PBS alone, DOTAP/DC-chol liposomes (0.4 μmol/...
<p>AFCo2 or PLc (100 µg) was admixed with 20 µg of OVA and administered by i.n route to BALB/c mice....
<p>Immunization by intra-rectal route with ovalbumin as antigen (OVA), with cholera toxin (CT) (n = ...
<p>(A) OMV-specific IgGs in BALF were detected in mice that were passively immunized with antiserum;...
<p>(A) IgG1 antibody titers in vaginal washings. Antibody titers are expressed as log<sub>10</sub> t...
<p>Fecal pellets were collected each week from individual mice and fecal extracts were assayed by EL...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
<p>C3H/HeN and C3H/Hen mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekl...
<p>Mice were intranasally immunized with ovalbumin (OVA) plus 0, 2.5, 5, 10, 25, 50, 100, 250, or 50...
Mice were immunized with OVA-PLGA 50:50 core-shell implant (A), with OVA-PLGA 100:0 core-shell impla...
<p>(A) Immunization regimen for evaluation of route of administration. ELISA plates were coated with...
<p>Mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekly intervals. One gro...
<p>(A-D and F-H) <i>Cd155<sup>−/−</sup></i> mice (n = 12) and WT littermate (n = 12) were immunize...
The levels of OVA-specific (A) IgE, (B) IgG1 and (C) IgG2a in BALF were detected in mice from PBS, O...
<p>BALB/c female mice were immunized intranasally with PBS alone, DOTAP/DC-chol liposomes (0.4 μmol/...
<p>AFCo2 or PLc (100 µg) was admixed with 20 µg of OVA and administered by i.n route to BALB/c mice....
<p>Immunization by intra-rectal route with ovalbumin as antigen (OVA), with cholera toxin (CT) (n = ...
<p>(A) OMV-specific IgGs in BALF were detected in mice that were passively immunized with antiserum;...